Cargando…
Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors
SIMPLE SUMMARY: Advanced neuroendocrine tumors originating in the intestinal tract and pancreas are treated with biologics that activate somatostatin receptors (lanreotide and octreotide), small molecule drugs that target the mTOR (everolimus) and VEGF and other signaling pathways (sunitinib), chemo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776394/ https://www.ncbi.nlm.nih.gov/pubmed/36551599 http://dx.doi.org/10.3390/cancers14246114 |